Search Results

A-Alpha Bio Collaborates with Amgen to Identify and Validate Ligase-Target Pairs for Molecular Glue Discovery

• Authors : PR Newswire

Subjects: Washington

• Source: PR Newswire US. 09/26/2023.

Record details

A-Alpha Bio Partners with Kymera Therapeutics to Discover Novel Interactions for Molecular Glue Discovery

• Authors : PR Newswire

Subjects: Washington

• Source: PR Newswire US. 12/16/2021.

Record details

Atomwise and Bridge Biotherapeutics Sign $1B Deal to Unlock Blockbuster Potential in Inflammation

• Authors : Atomwise Inc.

• Source: Business Wire (English). 03/09/2020.

Record details

A-Alpha Bio Announces Collaboration with Bristol Myers Squibb to Discover Molecular Glue Targets for Protein Degradation

• Authors : PR Newswire

Subjects: Washington

• Source: PR Newswire US. 08/23/2022.

Record details

Merus NV Business Update - Final

• Source: Fair Disclosure Wire (Quarterly Earnings Reports). 10/16/2023.

Record details

Peloton Therapeutics Launches Ubiquitin Ligase Research Platform

• Authors : Peloton Therapeutics, Inc.

• Source: Business Wire (English). 06/15/2017.

Record details

EpiBiologics Extracellular Protein Degraders Demonstrate Robust Preclinical Anti-tumor Activity and Survival Benefit

• Authors : EpiBiologics

• Source: Business Wire (English). 04/08/2024.

Record details

Bayer AG Pharmaceuticals R&D Event - Final

• Source: Fair Disclosure Wire (Quarterly Earnings Reports). 06/28/2023.

Record details

Monte Rosa Therapeutics Discloses $32.5 Million Financing

• Authors : Monte Rosa Therapeutics

• Source: Business Wire (English). 05/26/2020.

Record details

Proteostasis Therapeutics Presents Data at Multiple Scientific Conferences Highlighting Novel Approach to Neurodegenerative Diseases and Cystic Fibrosis

• Authors : Proteostasis Therapeutics, Inc.

• Source: Business Wire (English). 08/14/2012.

Record details